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Received November 1, 2010; accepted January 10, 2011AbstractBackground: Although the effects of uterine arterial embolization (UAE) for the control of post-partum hemorrhage on menstruation, fertility
and future pregnancy have been reported before, domestic reports on long-term outcomes are lacking.
Methods: From April 2001 to March 2005, 9 patients who underwent UAE for post-partum hemorrhage were evaluated retrospectively. The
analyses included both immediate and long-term outcome, including menstruation, future fertility and subsequent pregnancies.
Results: The median follow-up was 82 months, ranging from 63 months to 108 months. All the women had regular menstruation after UAE
treatment, but 5 had hypomenorrhea. Four women attempted pregnancy, and 3 had successful term deliveries. One woman was infertile.
Conclusion: UAE appeared to be a safe procedure. Hypomenorrhea was common after UAE treatment (55.6%), although regular menstruation
returned successfully. Future pregnancy seemed possible, and without complications.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Post-partum hemorrhage (PPH) remains one of the leading
causes of maternal deaths and may occur immediately or
several hours or days after delivery.1,2 Primary PPH is defined
as a loss of more than 500 mL of blood or more during the first
24 hours after delivery.3 Hemorrhage that occurs after the first
24 hours and up to 6 weeks after birth is classified as
secondary PPH. Potential causes of hemorrhage include
uterine atony, retained products of conception, placental
abnormalities, uterine inversion, uterine rupture, lower genital
tract lacerations, cervical pregnancy, and coagulopathies.4* Corresponding author. Dr. Ming-Jie Yang, Department of Obstetrics and
Gynecology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road,
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doi:10.1016/j.jcma.2011.04.004Care of these patients requires rapid identification of the
cause and control of the bleeding, because of the potentially
life-threatening situation.5 In most cases, severe PPH can be
managed by conservative treatment which is based on the
administration of uterotonic drugs, vaginal packing, and
surgical repair of genital tract lacerations.6 When bleeding
fails to respond to conservative treatment, the use of vascular
ligation or hysterectomy may be needed.2,7,8 Since the late
1960s, transcatheter arterial embolization procedures have
been used for the control of pelvic hemorrhage resulting from
malignancy, trauma, and radiation.9 This furthermore seems to
be an alternative procedure for the management of PPH. In
1979, transcatheter embolization to control post-partum
bleeding was initially described by Brown et al.10 Subse-
quently, several authors have reported the usefulness of this
technique as first-line treatment for PPH in those patients
refractory to conservative treatment.11 Data on the long-termhinese Medical Association. All rights reserved.
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fertility are also available.12 Most of the reports indicate that
arterial embolization is a safe and effective procedure and
offers patients a fertility-preserving option,13 although there
are always some concerns.14,15 However, it seems that all of
the reports are restricted to Western racial groups, and there is
a lack of data on Eastern racial groups, although some similar
reports, such as those regarding uterine vessel occlusion per-
formed by laparoscopy or laparotomy, can be found.8,16,17
Therefore, it would be of interest to know whether racial
group differences influence the outcome of transcatheter
embolization. The objective of this report, therefore, is to
share our experience using transcatheter UAE in the
management of severe obstetrical hemorrhage in 9 patients of
Asian descent.
2. Methods
From April, 2001 to March, 2005, 9 patients who were
treated with transcatheter UAE were evaluated retrospectively.
A digital substration angiography of the bilateral internal
iliac arteries was performed by the interventional radiologist
(Dr Tseng) using the right-side femoral approach with a 4F
cobra-shaped catheter (Cobra; Cordis, the Netherlands) and
a 0.035-inch-diameter hydrophilic polymer-coated guide-wire
(Radiofocus; Terumo, Japan). Bilateral uterine arteries were
also catheterized using a 2.5 F coaxial catheter (Renegeade,
Boston Scientific, MA, USA). Embolization of the uterine
arteries was carried out preferentially with absorbable poly-
vinyl alcohol dehydrated particle (PVA, Ultra-Drivalon;
CatheNet-Science, France), or gelatin sponge pieces (Gel-
foam; Spongostan, Johnson & Johnson Medical Limited, UK)
or both. Subsequently, vascular occlusion was confirmed by
repeat angiography, and uterotonic agents were administrated;
further treatments were performed when necessary.Table 1
General characteristics of the patients
Case Age (yr) Parity History Labor condition
(gestational wk)
1 31 G6P2A3 C/S twice, D &C triple times C/S (39)
2 29 G2P0A1 D&C once C/S (39)
3 42 G6P2A3 NSD twice, D&C triple times Induction (40)
4 36 G3P1A1 D&C once C/S (39)
5 25 G1P0A0 IVF þ ET with triple
pregnancy, OHSS
C/S (36)
6 38 G5P3A1 C/S twice; GDM; tocolytic
treatment
C/S (37)
7 38 G2P1A0 NSD once Induction (39)
8 39 G6P1A4 NSD once, D&C triple times Induction (40)
9 30 G1P0A0 Induction (40)
C/S ¼ cesarean section; EBL ¼ estimated blood loss; G ¼ gravida; GDM ¼ g
OHSS ¼ ovarian hyperstimulation syndrome; P ¼ para; UAE ¼ uterine artery em3. Results
The general characteristics of the patients are shown in
Table 1. The mothers’ median age was 35 years (range 25e42)
and the babies’ median gestational age was 38 weeks (36e40
weeks). Eight pregnancies were spontaneous, and 1 involved
assisted reproductive technologies (IVF, in vitro fertilization),
resulting in triple pregnancies. All deliveries were scheduled,
including 5 cesarean sections (C/S) and 4 inductions with
normal vaginal delivery. The main cause of PPH in 8 patients
(89%, 8/9) was placental accreta; one patient had atony. One
patient was also complicated with complete placenta previa.
The embolization procedures involved bilateral uterine arteries
in 6 cases, right uterine artery in 2 cases, and left uterine artery
in 1 case. Absorbable polyvinyl alcohol, Gelfoam, or both,
was used for embolization in all cases (Table 2). After the
procedure, 4 women had abdominal pain or lower back pain
(Visual analog scores are 4, 6, 4, 5 right after UAE, five days
later, VAS score 1, 2, 1, 2), 2 women had urinary frequency,
and 1 woman had pelvic inflammatory disease (under control
of oral antibiotics for 14 days).
The median follow-up was 82 months, ranging from 63
months to 108 months (Table 3). Menstruation returned for all
women after UAE or ceasing breast-feeding, but 5 reported
hypomenorrhea. None had dyspareuria, change in sexual
function, or menopausal symptoms or signs. None were
menopausal during the follow-up period.
Four women attempted pregnancy, and 3 had successful
and uncomplicated term deliveries. One woman was infertile,
and the cause was unexplained.
4. Discussion
PPH is one of the main causes of maternal mortality
throughout the world, and occurs in approximately 5% of allClinical diagnosis EBL (mL)
hemoglobin change
before UAE
Clinical managements
before UAE
Placenta accreta >2000
5.3 g/dL
Oxytocin, methylergonovine
Placenta accrete 6.1 g/dL Oxytocin, methylergonovine
Placenta accreta >2000
4.4 g/dL
Packing; massage; oxytocin,
methylergonovine
Placenta accreta >1000
3.3 g/dL
Packing; massage; pitocin
Atony >2000
6.6 g/dL
Oxytocin, methylergonovine
Total placenta previs
Placenta accreta
>2000
5.1 g/dL
Oxytocin, methylergonovine
Retained placenta
Placenta accreta
>1000
3.2 g/dL
Packing; massage; oxytocin,
methylergonovine
Placenta accreta >2000
6.3 g/dL
Packing; massage; oxytocin,
methylergonovine
Placenta accreta >2000
6.1 g/dL
Packing; Massage; oxytocin,
methylergonovine
estational diabetes; IVF þ ET ¼ in vitro fertilization and embryo transfer;
bolization.
Table 2
Summary of embolization data
Patient No. Angiogram finding Embolization Material Successful Complication
1 Active bleeding of bilateral uterine
artery
Yes (bilateral uterine artery) Ivalon Yes (no more active bleeding) None
2 Abnormal hypervascular stains in
uterine cavity especially from left
uterine artery
Yes (bilateral uterine artery) Ivalon Yes (no residual hypervascular
stains)
None
3 Contrast extravasation from right
uterine artery
Yes (right uterine artery) gelfoam Yes (loss of contrast leakage) None
4 No definite active bleeding Yes (bilateral uterine artery) Ivalon; gelfoam Yes None
5 Contrast extravasation and pooling
into the uterine cavity from left
uterine artery
Yes (left uterine artery) Ivalon Yes (total occlusion) None
6 Extravasation and pooling into the
uterine cavity more in right side
Yes (bilateral uterine artery) Ivalon Yes (total obliteration) None
7 Bilateral faint contrast extravasation
and pooling into the uterine cavity
Yes (bilateral uterine artery) Ivalon; gelfoam Yes (total occlusion) None
8 Active bleeding of right uterine
artery
Yes (right uterine artery) Ivalon; gelfoam Yes (total obliteration) None
9 More prominent in right side Yes (bilateral uterine artery) Ivalon Yes (decreased vascularity) None
Ivalon: PVA: 250e355 mm polyvinyl alcohol particle (Ultra-Drivalon), 50e100 mg; Gelfoam: gelatin sponge pieces.
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primary PPH (70%),18 other causes, including trauma (lacer-
ation) to the lower genital tract and retained placental tissue
should be considered; the latter, especially, contributes to
maternal morbidity rather than mortality.19 Treatment of PPH
is centered on resuscitation of the patient and arrest of the
bleeding. Strategies range from conservative to destructive.
Conservative management includes uterine massage, vaginal
packing, uterotonic drugs, and surgical repair of lower genital
tract lacerations. If these attempts fail, intensive treatment,
including surgical ligation of the internal iliac arteries or
uterine arteries and transcatheter arterial embolization follows.
These rescue methods can avoid the need for the most of
immediate or delayed post-partum hysterectomies,2 because
the overall successful rate of UAE is more than 90%.20e22 In
this study, the UAE procedure had completely cured the moreTable 3
Menstrual pattern and fertility compared with those before uterine artery
embolization
Patients Menstruation pattern
duration/interval
Amount Fertility
1 Similar (3e4/25 d) Similar Infertility
2 Similar (5e7/28 d) Hypomenorrhea C/S 18 mo after UAE
(GA 37 wk, male, 3574 g)
C/S 46 mo after UAE
(GA 37 wk, female, 3000 g)
3 Similar (3e4/28 d) Hypomenorrhea No attempt
4 Similar (3e4/26 d) Hypomenorrhea No attempt
5 Similar (5e7/22 d) Similar No attempt
6 Similar (3e4/28 d) Hypomenorrhea No attempt
7 Similar (5e7/29 d) Similar C/S at 17 mo after UAE
(GA 38 wk, male, 3340 g)
8 Similar (3e4/28 d) Hypomenorrhea No attempt
9 Similar (3e5/29 d) Similar C/S at 36 mo after UAE
(GA 38 wk, female, 3230 g)
C/S ¼ cesarean section; GA ¼ gestational age; UAE ¼ uterine artery
embolization.troublesome PPH successfully and avoided hysterectomy.
Furthermore, the UAE complication rate is low and the
occurrence of complications is ‘operator dependent’; adequate
expertise and skill can keep the complication rate to
a minimum of less than 1.6%.23 Complications include those
related to the angiography procedure itself, such as anaphy-
laxis and renal toxicity, and those related to embolization, such
as embolus dislodgment leading to tissue necrosis (bladder and
rectal wall necrosis) and other rare conditions, such as fever,
nerve injury, and late rebleeding.23
Numerous cases of pregnancy after bilateral ligation of the
internal iliac arteries24 or the uterine arteries25 have been
reported in the literature. However, currently available data are
insufficient to routinely offer UAE to women who wish to
preserve or enhance their fertility.14 Since the possibility of
a negative impact on the ovarian function is always a concern
when using the UAE procedure, there is an argument about the
deterioration of ovarian function after UAE.26,27 Recently,
long-term follow-up and implications for pregnancy have also
been reported after UAE.12,28 According to these reports, the
influence on fertility is minimal, although some concerns are
still raised based on the experience with fibroid
treatment.12e16 In fact, in this study, pregnancy occurred
spontaneously in those patients who had a desire. However,
one important sequela that should be emphasized is the
recurrence of severe post-partum hemorrhage.23
Although all patients returned to a normal menstrual cycle
after UAE, the findings in this study are consistent with those
of previous reports,28 and even consistent with uterine vessel
occlusion performed by laparoscopic uterine vessel occlusion
either with or without simultaneous blockage of the uterine
vessels and the anastomotic sites between the uterine vessels
and the ovarian vessels.14,15 However, the amount of menstrual
blood flow was decreased significantly in this study, and more
than half of the patients reported hypomenorrhea. Because
UAE is becoming a well-accepted choice in the management
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hypermenorrhea or menorrhagia, the findings in our study are
not so surprising. However, a potentially compromised ovarian
function may actually be present. In our recent publica-
tions,14,15 we found that different approaches to treating
blockage of the uterine feeding vessels result in different
patterns of follicular stimulating hormone changes and thera-
peutic outcomes. The more uterine feeding vessels are
occluded, the more effective the therapeutic outcomes, but
more elevated basal levels of follicular stimulating hormone
are found. Therefore, the ovarian function or future fertility
outcome is still arguable.
In this study, there are some limitations including the small
sample size, the lack of hormone status or menstrual flow data
before UAE and also lack of furthermore evaluation of right
decision timing of UAE when after multiple procedures failed.
In conclusion, selective UAE is a safe and effective method
to control obstetric intractable hemorrhage in those case with
failed medical or obstetrical conservative treatment. This
technique might be considered as a choice before performing
a furthermore destructive surgery. Preservation of the uterus
remains an indisputable advantage of UAE for women desiring
another pregnancy. With the satisfactory results mentioned
above, it seems that a patient with severe post-partum hemor-
rhage the UAE could be an appropriate method in Taiwan.References
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